Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
百苓痛风消颗粒治疗急性痛风性关节炎(湿热瘀阻证)的随机、双盲、安慰剂平行对照、多中心 IIa 期临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase IIa clinical trial of Bailing Tongfengxiao granules in the treatment of acute gouty arthritis (damp-heat and blood stasis syndrome)
初步评价百苓痛风消颗粒治疗急性痛风性关节炎(湿热瘀阻证)的有效性和安全性,探索最佳剂量,为后续临床试验提供科学依据。
[Translation] To preliminarily evaluate the effectiveness and safety of Bailing Tongfengxiao Granules in the treatment of acute gouty arthritis (damp-heat and blood stasis syndrome), explore the optimal dose, and provide a scientific basis for subsequent clinical trials.
100 Clinical Results associated with Guangzhou Fanhoutang Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Guangzhou Fanhoutang Pharmaceutical Technology Co., Ltd.
100 Deals associated with Guangzhou Fanhoutang Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Guangzhou Fanhoutang Pharmaceutical Technology Co., Ltd.